Aqr Capital Management LLC Oncocyte Corp Transaction History

Aqr Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.86 - $1.53 $11,620 - $20,673	-13,512 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.15 - $2.25 $39,942 - $78,149	-34,733 Reduced 71.99%	13,512 $20,000
Q4 2021 Feb 14, 2022	SELL	$2.04 - $3.59 $12,821 - $22,563	-6,285 Reduced 11.53%	48,245 $105,000
Q3 2021 Nov 15, 2021	SELL	$3.53 - $5.89 $225,238 - $375,823	-63,807 Reduced 53.92%	54,530 $194,000
Q2 2021 Aug 16, 2021	BUY	$3.77 - $6.0 $260,013 - $413,814	68,969 Added 139.7%	118,337 $679,000
Q1 2021 May 17, 2021	BUY	$2.39 - $6.5 $117,989 - $320,892	49,368 New	49,368 $256,000
Q1 2020 May 15, 2020	SELL	$1.76 - $3.02 $60,086 - $103,102	-34,140 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$1.51 - $2.27 $53,810 - $80,893	-35,636 Reduced 51.07%	34,140 $77,000
Q3 2019 Nov 14, 2019	BUY	$1.59 - $2.51 $110,943 - $175,137	69,776 New	69,776 $147,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $260M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.